Quanex Building Products Corporation (NYSE:NX)
(“Quanex” or the “Company”) today announced its results for the
three months ended July 31, 2020.
The Company reported the following selected
financial results:
|
|
Three Months Ended July 31, |
|
Nine Months Ended July 31, |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
Net
Sales |
|
$212.1 |
|
|
$238.5 |
|
|
$596.2 |
|
|
$653.5 |
|
Gross
Margin |
|
$49.7 |
|
|
$57.1 |
|
|
$126.6 |
|
|
$142.2 |
|
Gross Margin % |
|
|
23.4% |
|
|
|
23.9% |
|
|
|
21.2% |
|
|
|
21.8% |
|
Net Income
(Loss) |
|
$10.8 |
|
|
$11.8 |
|
|
$16.3 |
|
|
|
($15.8) |
|
Diluted
EPS |
|
$0.33 |
|
|
$0.36 |
|
|
$0.50 |
|
|
|
($0.48) |
|
|
|
|
|
|
|
|
|
|
Adjusted Net
Income |
|
$11.1 |
|
|
$13.7 |
|
|
$18.7 |
|
|
$17.8 |
|
Adjusted
Diluted EPS |
|
$0.34 |
|
|
$0.41 |
|
|
$0.57 |
|
|
$0.54 |
|
Adjusted
EBITDA |
|
$27.7 |
|
|
$32.8 |
|
|
$65.2 |
|
|
$68.2 |
|
Adjusted EBITDA Margin % |
|
|
13.1% |
|
|
|
13.7% |
|
|
|
10.9% |
|
|
|
10.4% |
|
|
|
|
|
|
|
|
|
|
Cash Provided by Operating Activities |
$45.1 |
|
|
$29.9 |
|
|
$47.6 |
|
|
$30.0 |
|
Free Cash
Flow |
|
$40.7 |
|
|
$25.9 |
|
|
$26.9 |
|
|
$13.1 |
|
|
|
|
|
|
|
|
|
|
(See Non-GAAP Terminology Definitions and
Disclaimers section, Non-GAAP Financial Measure Disclosure table
Selected Segment Data table and Free Cash Flow Reconciliation table
for additional information) |
|
|
|
|
|
|
|
|
|
George Wilson, President and Chief Executive
Officer, stated, “Despite the impact from the COVID-19 pandemic,
third quarter results proved better than we expected and exceeded
the guidance we provided on our last earnings
call. Volumes increased steadily throughout
the quarter, especially in Europe, and we remain optimistic on the
recovery. We continue to focus on managing working capital
and generating cash. As a result, we realized an increase of
over 50% in cash provided by operating activities as compared to
the same period of 2019. We were also able to repay $78
million of bank debt during the quarter, $50 million of which was
drawn as a precautionary measure in response to the pandemic, and
our leverage ratio of Net Debt to LTM Adjusted EBITDA improved to a
level below where we ended fiscal 2019. We have worked
tirelessly over the past several years to make sure we have a
flexible capital structure and a strong balance sheet, which has
left our Company well positioned to navigate the challenges
presented by the COVID-19 pandemic.”
Consistent with most companies, we withdrew
guidance for fiscal 2020 in March due to the uncertainty
surrounding the COVID-19 pandemic. Our results have been
negatively impacted by the pandemic; however, we continue to be
positively surprised by the pace at which demand for our products
has returned. As such, we are now comfortable providing full year
2020 guidance of $832 million to $837 million in net sales and $97
million to $102 million in Adjusted EBITDA*. (See Non-GAAP
Terminology Definitions and Disclaimers section for additional
information)
*When Quanex provides expectations for Adjusted
EBITDA on a forward-looking basis, a reconciliation of the
differences between the non-GAAP expectations and corresponding
GAAP measures is generally not available without unreasonable
effort. Certain items required for such a reconciliation are
outside of the Company’s control and/or cannot be reasonably
predicted or estimated, such as the provision for income taxes.
Third Quarter 2020 Results
Summary
The decrease in net sales during the third
quarter of 2020 was largely attributable to softer demand related
to the COVID-19 pandemic. The Company’s two manufacturing
facilities in the UK were shut down in compliance with government
orders on March 25, 2020, and manufacturing operations at those
plants did not restart until mid-to-late May. However, volume
across all segments increased significantly in June and net sales
in July exceeded prior year on a consolidated basis. (See Sales
Analysis table for additional information)
The decrease in reported earnings was primarily
due to reduced operating leverage as a result of softer volumes
related to the pandemic.
Balance Sheet & Liquidity
Update
As of July 31, 2020, the Company’s leverage
ratio of Net Debt to LTM Adjusted EBITDA improved to 1.1x.
Quanex expects to exit fiscal 2020 with a leverage ratio of Net
Debt to LTM Adjusted EBITDA at or below 1.0x. (See
Non-GAAP Terminology Definitions and Disclaimers section for
additional information)
The Company’s liquidity increased to $223.2
million as of July 31, 2020, consisting of $41.1 million in cash on
hand plus availability under its Senior Secured Revolving Credit
Facility due 2023, less letters of credit outstanding.
Share Repurchases
Quanex’s Board of Directors authorized a $60
million share repurchase program in September of 2018.
Repurchases under this program will be made in open market
transactions or privately negotiated transactions, subject to
market conditions, applicable legal requirements and other relevant
factors. The program does not have an expiration date or a
limit on the number of shares that may be repurchased. The
Company did not repurchase any shares of common stock during the
three months ended July 31, 2020. As of July 31, 2020,
approximately $11.7 million remained under the existing share
repurchase authorization.
Recent Events
Quanex’s Board of Directors declared a quarterly
cash dividend of $0.08 per share on the Company’s common stock,
payable September 30, 2020, to shareholders of record on September
16, 2020.
Conference Call and Webcast
Information
The Company has scheduled a conference call for
Friday, September 4, 2020, at 11:00 a.m. ET (10:00 a.m. CT).
To participate in the conference call dial (877) 388-2139 for
domestic callers and (541) 797-2983 for international callers, in
both cases using the conference passcode 6194308, and ask for the
Quanex call a few minutes prior to the start time. A link to
the live audio webcast will also be available on the Company’s
website at http://www.quanex.com in the Investors section under
Presentations & Events. A telephonic replay of the call
will be available approximately two hours after the live broadcast
ends and will be accessible through September 11, 2020. To
access the replay dial (855) 859-2056 for domestic callers and
(404) 537-3406 for international callers, in both cases referencing
conference passcode 6194308.
About Quanex
Quanex Building Products Corporation is an
industry-leading manufacturer of components sold to Original
Equipment Manufacturers (OEMs) in the building products
industry. Quanex designs and produces energy-efficient
fenestration products in addition to kitchen and bath cabinet
components. For more information contact Scott Zuehlke,
Senior Vice President, Chief Financial Officer & Treasurer, at
713-877-5327 or scott.zuehlke@quanex.com.
Non-GAAP Terminology Definitions and
Disclaimers
Adjusted Net Income (Loss) (defined as net
income further adjusted to exclude purchase price accounting
inventory step-ups, transaction costs, certain severance charges,
gain/loss on the sale of certain fixed assets, restructuring
charges, asset impairment charges, other net adjustments related to
foreign currency transaction gain/loss and effective tax rates
reflecting impacts of adjustments on a with and without basis) and
Adjusted EPS are non-GAAP financial measures that Quanex believes
provide a consistent basis for comparison between periods and more
accurately reflects operational performance, as they are not
influenced by certain income or expense items not affecting ongoing
operations. EBITDA (defined as net income or loss before interest,
taxes, depreciation and amortization and other, net) and Adjusted
EBITDA (defined as EBITDA further adjusted to exclude purchase
price accounting inventory step-ups, transaction costs, certain
severance charges, gain/loss on the sale of certain fixed assets,
restructuring charges and asset impairment charges) are non-GAAP
financial measures that the Company uses to measure operational
performance and assist with financial decision-making. The
leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial
measure that the Company believes is useful to investors and
financial analysts in evaluating Quanex’s leverage. In
addition, with certain limited adjustments, this leverage ratio is
the basis for a key covenant in the Company’s credit
agreement. Free Cash Flow is a non-GAAP measure calculated
using cash provided by operating activities less capital
expenditures. Free Cash Flow is measured before application
of certain contractual commitments (including capital lease
obligations), and accordingly is not a true measure of Quanex’s
residual cash flow available for discretionary expenditures.
The Company believes that the presented non-GAAP measures provide a
consistent basis for comparison between periods, and will assist
investors in understanding Quanex’s financial performance when
comparing results to other investment opportunities. The
presented non-GAAP measures may not be the same as those used by
other companies. The Company does not intend for this
information to be considered in isolation or as a substitute for
other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
Statements that use the words “estimated,”
“expect,” “could,” “should,” “believe,” “will,” “might,” or similar
words reflecting future expectations or beliefs are forward-looking
statements. The forward-looking statements include, but are not
limited to, the following: impacts from public health issues
(including pandemics, such as the recent COVID-19 pandemic) on the
economy and the demand for Quanex’s products, the Company’s future
operating results, future financial condition, future uses of cash
and other expenditures, expenses and tax rates, expectations
relating to Quanex’s industry, and the Company’s future growth,
including any guidance discussed in this press release. The
statements and guidance set forth in this release are based on
current expectations. Actual results or events may differ
materially from this release. For a complete discussion of
factors that may affect Quanex’s future performance, please refer
to the Company’s Annual Report on Form 10-K for the fiscal year
ended October 31, 2019, and the Company’s Quarterly Reports on Form
10-Q under the sections entitled “Cautionary Note Regarding
Forward-Looking Statements” and “Risk Factors”. Any
forward-looking statements in this press release are made as of the
date hereof, and Quanex undertakes no obligation to update or
revise any forward-looking statements to reflect new information or
events.
QUANEX BUILDING PRODUCTS
CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF
INCOME (LOSS)(In thousands, except per share
data)(Unaudited)
|
|
Three Months Ended July 31, |
|
Nine Months Ended July 31, |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
Net
sales |
|
$ |
212,096 |
|
|
$ |
238,461 |
|
|
$ |
596,168 |
|
|
$ |
653,472 |
|
Cost of
sales |
|
|
162,427 |
|
|
|
181,357 |
|
|
|
469,586 |
|
|
|
511,292 |
|
Selling,
general and administrative |
|
|
21,973 |
|
|
|
25,718 |
|
|
|
62,818 |
|
|
|
77,466 |
|
Restructuring charges |
|
|
73 |
|
|
|
94 |
|
|
|
477 |
|
|
|
281 |
|
Depreciation
and amortization |
|
|
11,060 |
|
|
|
12,182 |
|
|
|
35,851 |
|
|
|
37,158 |
|
Asset
impairment charges |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
Operating
income (loss) |
|
|
16,563 |
|
|
|
19,110 |
|
|
|
27,436 |
|
|
|
(2,703 |
) |
Interest
expense |
|
|
(1,165 |
) |
|
|
(2,570 |
) |
|
|
(4,310 |
) |
|
|
(7,614 |
) |
Other,
net |
|
|
(220 |
) |
|
|
259 |
|
|
|
116 |
|
|
|
461 |
|
Income
(loss) before income taxes |
|
|
15,178 |
|
|
|
16,799 |
|
|
|
23,242 |
|
|
|
(9,856 |
) |
Income tax
expense |
|
|
(4,345 |
) |
|
|
(4,958 |
) |
|
|
(6,898 |
) |
|
|
(5,926 |
) |
Net income
(loss) |
|
$ |
10,833 |
|
|
$ |
11,841 |
|
|
$ |
16,344 |
|
|
$ |
(15,782 |
) |
|
|
|
|
|
|
|
|
|
Earnings
(loss) per common share, basic |
|
$ |
0.33 |
|
|
$ |
0.36 |
|
|
$ |
0.50 |
|
|
$ |
(0.48 |
) |
Earnings
(loss) per common share, diluted |
|
$ |
0.33 |
|
|
$ |
0.36 |
|
|
$ |
0.50 |
|
|
$ |
(0.48 |
) |
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
32,610 |
|
|
|
32,899 |
|
|
|
32,716 |
|
|
|
32,984 |
|
Diluted |
|
|
32,739 |
|
|
|
33,162 |
|
|
|
32,845 |
|
|
|
32,984 |
|
|
|
|
|
|
|
|
|
|
Cash
dividends per share |
|
$ |
0.08 |
|
|
$ |
0.08 |
|
|
$ |
0.24 |
|
|
$ |
0.24 |
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONCONDENSED CONSOLIDATED BALANCE
SHEETS(In thousands)(Unaudited)
|
July 31, 2020 |
|
October 31, 2019 |
ASSETS |
|
|
|
Current
assets: |
|
|
|
Cash and cash equivalents |
$ |
41,073 |
|
|
$ |
30,868 |
|
Accounts receivable, net |
|
84,479 |
|
|
|
82,946 |
|
Inventories, net |
|
63,939 |
|
|
|
67,159 |
|
Prepaid and other current assets |
|
7,930 |
|
|
|
9,353 |
|
Total current assets |
|
197,421 |
|
|
|
190,326 |
|
Property,
plant and equipment, net |
|
186,830 |
|
|
|
193,600 |
|
Operating
lease right-of-use assets |
|
49,644 |
|
|
|
- |
|
Goodwill |
|
146,932 |
|
|
|
145,563 |
|
Intangible
assets, net |
|
96,957 |
|
|
|
107,297 |
|
Other
assets |
|
9,007 |
|
|
|
8,324 |
|
Total assets |
$ |
686,791 |
|
|
$ |
645,110 |
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current
liabilities: |
|
|
|
Accounts payable |
$ |
58,676 |
|
|
$ |
63,604 |
|
Accrued liabilities |
|
33,916 |
|
|
|
39,221 |
|
Income taxes payable |
|
6,350 |
|
|
|
6,183 |
|
Current maturities of long-term debt |
|
690 |
|
|
|
746 |
|
Current operating lease liabilities |
|
7,307 |
|
|
|
- |
|
Total current liabilities |
|
106,939 |
|
|
|
109,754 |
|
Long-term
debt |
|
152,062 |
|
|
|
156,414 |
|
Noncurrent
operating lease liabilities |
|
42,740 |
|
|
|
- |
|
Deferred
pension and postretirement benefits |
|
11,375 |
|
|
|
13,322 |
|
Deferred
income taxes |
|
20,507 |
|
|
|
19,363 |
|
Other
liabilities |
|
13,230 |
|
|
|
16,070 |
|
Total liabilities |
|
346,853 |
|
|
|
314,923 |
|
Stockholders’ equity: |
|
|
|
Common stock |
|
373 |
|
|
|
374 |
|
Additional paid-in-capital |
|
253,144 |
|
|
|
254,673 |
|
Retained earnings |
|
193,989 |
|
|
|
185,703 |
|
Accumulated other comprehensive loss |
|
(28,819 |
) |
|
|
(33,817 |
) |
Treasury stock at cost |
|
(78,749 |
) |
|
|
(76,746 |
) |
Total stockholders’ equity |
|
339,938 |
|
|
|
330,187 |
|
Total liabilities and stockholders' equity |
$ |
686,791 |
|
|
$ |
645,110 |
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOW(In thousands)(Unaudited)
|
Nine Months Ended July 31, |
|
|
2020 |
|
|
|
2019 |
|
Operating activities: |
|
|
|
Net income (loss) |
$ |
16,344 |
|
|
$ |
(15,782 |
) |
Adjustments to reconcile net income (loss) to cash provided by
operating activities: |
|
|
|
Depreciation and amortization |
|
35,851 |
|
|
|
37,158 |
|
Stock-based compensation |
|
513 |
|
|
|
1,424 |
|
Deferred income tax |
|
438 |
|
|
|
1,930 |
|
Asset impairment charge |
|
- |
|
|
|
29,978 |
|
Other, net |
|
762 |
|
|
|
1,724 |
|
Changes in assets and liabilities: |
|
|
|
(Increase) decrease in accounts receivable |
|
(1,852 |
) |
|
|
323 |
|
Decrease (increase) in inventory |
|
3,553 |
|
|
|
(14,747 |
) |
Decrease (increase) in other current assets |
|
1,218 |
|
|
|
(1,022 |
) |
(Decrease) increase in accounts payable |
|
(1,878 |
) |
|
|
1,562 |
|
Decrease in accrued liabilities |
|
(7,611 |
) |
|
|
(15,366 |
) |
Increase in income taxes payable |
|
107 |
|
|
|
396 |
|
Increase in deferred pension and postretirement benefits |
|
573 |
|
|
|
2,351 |
|
Decrease in other long-term liabilities |
|
(181 |
) |
|
|
(143 |
) |
Other, net |
|
(276 |
) |
|
|
250 |
|
Cash
provided by operating activities |
|
47,561 |
|
|
|
30,036 |
|
Investing activities: |
|
|
|
Capital expenditures |
|
(20,673 |
) |
|
|
(16,984 |
) |
Proceeds from disposition of capital assets |
|
131 |
|
|
|
315 |
|
Cash used
for investing activities |
|
(20,542 |
) |
|
|
(16,669 |
) |
Financing activities: |
|
|
|
Borrowings under credit facilities |
|
114,500 |
|
|
|
66,500 |
|
Repayments of credit facility borrowings |
|
(119,000 |
) |
|
|
(84,000 |
) |
Repayments of other long-term debt |
|
(791 |
) |
|
|
(1,102 |
) |
Common stock dividends paid |
|
(7,910 |
) |
|
|
(7,990 |
) |
Issuance of common stock |
|
2,954 |
|
|
|
2,710 |
|
Payroll tax paid to settle shares forfeited upon vesting of
stock |
|
(454 |
) |
|
|
(330 |
) |
Purchase of treasury stock |
|
(6,693 |
) |
|
|
(6,336 |
) |
Cash used
for financing activities |
|
(17,394 |
) |
|
|
(30,548 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
580 |
|
|
|
(1,171 |
) |
Increase
(decrease) in cash and cash equivalents |
|
10,205 |
|
|
|
(18,352 |
) |
Cash and
cash equivalents at beginning of period |
|
30,868 |
|
|
|
29,003 |
|
Cash and
cash equivalents at end of period |
$ |
41,073 |
|
|
$ |
10,651 |
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONFREE CASH FLOW
RECONCILIATION(In thousands)(Unaudited)
The following table reconciles the Company's
calculation of Free Cash Flow, a non-GAAP measure, to its most
directly comparable GAAP measure. The Company defines Free Cash
Flow as cash provided by operating activities less capital
expenditures.
|
|
Three Months Ended July 31, |
|
Nine Months Ended July 31, |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
Cash
provided by operating activities |
|
$45,089 |
|
|
$29,893 |
|
|
$47,561 |
|
|
$30,036 |
|
Capital
expenditures |
|
|
(4,360 |
) |
|
|
(3,962 |
) |
|
|
(20,673 |
) |
|
|
(16,984 |
) |
Free Cash
Flow |
|
$40,729 |
|
|
$25,931 |
|
|
$26,888 |
|
|
$13,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONNON-GAAP FINANCIAL MEASURE
DISCLOSURE(In thousands, except per share
data)(Unaudited)
Reconciliation of Adjusted Net Income and Adjusted
EPS |
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
Nine Months Ended |
|
|
July 31, 2020 |
|
|
July 31, 2019 |
|
|
July 31, 2020 |
|
|
July 31, 2019 |
|
|
|
Net Income |
|
Diluted EPS |
|
|
Net Income |
|
Diluted EPS |
|
|
Net Income |
|
Diluted EPS |
|
|
Net (Loss) Income |
|
Diluted EPS |
|
Net income (loss) as reported |
|
$ |
10,833 |
|
|
$ |
0.33 |
|
|
|
$ |
11,841 |
|
|
$ |
0.36 |
|
|
|
$ |
16,344 |
|
|
$ |
0.50 |
|
|
|
$ |
(15,782 |
) |
|
$ |
(0.48 |
) |
|
Reconciling
items from below |
|
|
280 |
|
|
|
0.01 |
|
|
|
|
1,809 |
|
|
|
0.05 |
|
|
|
|
2,387 |
|
|
|
0.07 |
|
|
|
|
33,595 |
|
|
|
1.02 |
|
|
Adjusted net
income and adjusted EPS |
|
$ |
11,113 |
|
|
$ |
0.34 |
|
|
|
$ |
13,650 |
|
|
$ |
0.41 |
|
|
|
$ |
18,731 |
|
|
$ |
0.57 |
|
|
|
$ |
17,813 |
|
|
$ |
0.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Adjusted EBITDA |
|
Three Months EndedJuly 31, 2020 |
|
|
Three Months EndedJuly 31, 2019 |
|
|
Nine Months EndedJuly 31, 2020 |
|
|
Nine Months EndedJuly 31, 2019 |
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
Net income
(loss) as reported |
|
$ |
10,833 |
|
|
|
|
|
$ |
11,841 |
|
|
|
|
|
$ |
16,344 |
|
|
|
|
|
$ |
(15,782 |
) |
|
|
|
Income tax
expense |
|
|
4,345 |
|
|
|
|
|
|
4,958 |
|
|
|
|
|
|
6,898 |
|
|
|
|
|
|
5,926 |
|
|
|
|
Other,
net |
|
|
220 |
|
|
|
|
|
|
(259 |
) |
|
|
|
|
|
(116 |
) |
|
|
|
|
|
(461 |
) |
|
|
|
Interest
expense |
|
|
1,165 |
|
|
|
|
|
|
2,570 |
|
|
|
|
|
|
4,310 |
|
|
|
|
|
|
7,614 |
|
|
|
|
Depreciation
and amortization |
|
|
11,060 |
|
|
|
|
|
|
12,182 |
|
|
|
|
|
|
35,851 |
|
|
|
|
|
|
37,158 |
|
|
|
|
EBITDA |
|
|
27,623 |
|
|
|
|
|
|
31,292 |
|
|
|
|
|
|
63,287 |
|
|
|
|
|
|
34,455 |
|
|
|
|
Reconciling
items from below |
|
|
73 |
|
|
|
|
|
|
1,495 |
|
|
|
|
|
|
1,875 |
|
|
|
|
|
|
33,777 |
|
|
|
|
Adjusted
EBITDA |
|
$ |
27,696 |
|
|
|
|
|
$ |
32,787 |
|
|
|
|
|
$ |
65,162 |
|
|
|
|
|
$ |
68,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciling Items |
|
Three Months EndedJuly 31, 2020 |
|
|
Three Months EndedJuly 31, 2019 |
|
|
Nine Months EndedJuly 31, 2020 |
|
|
Nine Months EndedJuly 31, 2019 |
|
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
Net
sales |
|
$ |
212,096 |
|
|
$ |
- |
|
|
|
$ |
238,461 |
|
|
$ |
- |
|
|
|
$ |
596,168 |
|
|
$ |
- |
|
|
|
$ |
653,472 |
|
|
$ |
- |
|
|
Cost of
sales |
|
|
162,427 |
|
|
|
- |
|
|
|
|
181,357 |
|
|
|
- |
|
|
|
|
469,586 |
|
|
|
- |
|
|
|
|
511,292 |
|
|
|
- |
|
|
Selling,
general and administrative |
|
|
21,973 |
|
|
|
- |
|
|
|
|
25,718 |
|
|
|
(1,401 |
) |
(1) |
|
|
62,818 |
|
|
|
(1,398 |
) |
(1) |
|
|
77,466 |
|
|
|
(3,518 |
) |
(1) |
Restructuring charges |
|
|
73 |
|
|
|
(73 |
) |
(2) |
|
|
94 |
|
|
|
(94 |
) |
(2) |
|
|
477 |
|
|
|
(477 |
) |
(2) |
|
|
281 |
|
|
|
(281 |
) |
(2) |
Asset
impairment charges |
|
|
- |
|
|
|
- |
|
|
|
|
- |
|
|
|
- |
|
|
|
|
- |
|
|
|
- |
|
|
|
|
29,978 |
|
|
|
(29,978 |
) |
(3) |
EBITDA |
|
|
27,623 |
|
|
|
73 |
|
|
|
|
31,292 |
|
|
|
1,495 |
|
|
|
|
63,287 |
|
|
|
1,875 |
|
|
|
|
34,455 |
|
|
|
33,777 |
|
|
Depreciation
and amortization |
|
|
11,060 |
|
|
|
- |
|
|
|
|
12,182 |
|
|
|
- |
|
|
|
|
35,851 |
|
|
|
(968 |
) |
(4) |
|
|
37,158 |
|
|
|
- |
|
|
Operating
income (loss) |
|
|
16,563 |
|
|
|
73 |
|
|
|
|
19,110 |
|
|
|
1,495 |
|
|
|
|
27,436 |
|
|
|
2,843 |
|
|
|
|
(2,703 |
) |
|
|
33,777 |
|
|
Interest
expense |
|
|
(1,165 |
) |
|
|
- |
|
|
|
|
(2,570 |
) |
|
|
- |
|
|
|
|
(4,310 |
) |
|
|
- |
|
|
|
|
(7,614 |
) |
|
|
- |
|
|
Other,
net |
|
|
(220 |
) |
|
|
458 |
|
(5) |
|
|
259 |
|
|
|
(112 |
) |
(5) |
|
|
116 |
|
|
|
390 |
|
(5) |
|
|
461 |
|
|
|
(67 |
) |
(5) |
Income
(loss) before income taxes |
|
|
15,178 |
|
|
|
531 |
|
|
|
|
16,799 |
|
|
|
1,383 |
|
|
|
|
23,242 |
|
|
|
3,233 |
|
|
|
|
(9,856 |
) |
|
|
33,710 |
|
|
Income tax
expense |
|
|
(4,345 |
) |
|
|
(251 |
) |
(6) |
|
|
(4,958 |
) |
|
|
426 |
|
(6) |
|
|
(6,898 |
) |
|
|
(846 |
) |
(6) |
|
|
(5,926 |
) |
|
|
(115 |
) |
(6) |
Net income
(loss) |
|
$ |
10,833 |
|
|
$ |
280 |
|
|
|
$ |
11,841 |
|
|
$ |
1,809 |
|
|
|
$ |
16,344 |
|
|
$ |
2,387 |
|
|
|
$ |
(15,782 |
) |
|
$ |
33,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings (loss) per share |
|
$ |
0.33 |
|
|
|
|
|
$ |
0.36 |
|
|
|
|
|
$ |
0.50 |
|
|
|
|
|
$ |
(0.48 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Transaction and
advisory fees, $1.3 million related to executive severance charges
in the nine months ended 2020, $1.2 million of executive severance
charges in the three and nine months ended 2019, and $1.2 million
of severance charges related to a reorganization in the nine months
ended 2019. |
|
(2) Restructuring
charges relate to the closure of manufacturing plant
facilities. |
|
(3) Asset impairment
charges relate to goodwill impairment in the North American Cabinet
Components
segment. |
|
(4) Accelerated
depreciation related to the closure of a North American Cabinet
Components plant. |
|
(5) Foreign currency
transaction losses
(gains). |
|
(6) Impact on a with
and without basis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONSELECTED SEGMENT DATA(In
thousands)(Unaudited)
This table provides
gross margin, operating income (loss), EBITDA, and Adjusted EBITDA
by reportable segment. Non-operating expense and income tax expense
are not allocated to the reportable segments. |
|
|
NA Fenestration |
|
EU Fenestration |
|
NA CabinetComponents |
|
UnallocatedCorp & Other |
|
Total |
Three months ended July 31, 2020 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
122,386 |
|
|
$ |
38,265 |
|
|
$ |
51,925 |
|
|
$ |
(480 |
) |
|
$ |
212,096 |
|
Cost of sales |
|
|
92,639 |
|
|
|
25,845 |
|
|
|
44,218 |
|
|
|
(275 |
) |
|
|
162,427 |
|
Gross Margin |
|
|
29,747 |
|
|
|
12,420 |
|
|
|
7,707 |
|
|
|
(205 |
) |
|
|
49,669 |
|
Gross Margin % |
|
|
24.3 |
% |
|
|
32.5 |
% |
|
|
14.8 |
% |
|
|
|
|
23.4 |
% |
Selling, general and administrative |
|
|
11,922 |
|
|
|
4,748 |
|
|
|
4,634 |
|
|
|
669 |
|
|
|
21,973 |
|
Restructuring charges |
|
|
71 |
|
|
|
- |
|
|
|
2 |
|
|
|
- |
|
|
|
73 |
|
Depreciation and amortization |
|
|
5,371 |
|
|
|
2,307 |
|
|
|
3,264 |
|
|
|
118 |
|
|
|
11,060 |
|
Operating income (loss) |
|
|
12,383 |
|
|
|
5,365 |
|
|
|
(193 |
) |
|
|
(992 |
) |
|
|
16,563 |
|
Depreciation and amortization |
|
|
5,371 |
|
|
|
2,307 |
|
|
|
3,264 |
|
|
|
118 |
|
|
|
11,060 |
|
EBITDA |
|
|
17,754 |
|
|
|
7,672 |
|
|
|
3,071 |
|
|
|
(874 |
) |
|
|
27,623 |
|
Restructuring charges |
|
|
71 |
|
|
|
- |
|
|
|
2 |
|
|
|
- |
|
|
|
73 |
|
Adjusted EBITDA |
|
$ |
17,825 |
|
|
$ |
7,672 |
|
|
$ |
3,073 |
|
|
$ |
(874 |
) |
|
$ |
27,696 |
|
Adjusted EBITDA Margin % |
|
|
14.6 |
% |
|
|
20.0 |
% |
|
|
5.9 |
% |
|
|
|
|
13.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
Three months ended July 31, 2019 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
136,259 |
|
|
$ |
44,326 |
|
|
$ |
58,689 |
|
|
$ |
(813 |
) |
|
$ |
238,461 |
|
Cost of sales |
|
|
101,693 |
|
|
|
30,708 |
|
|
|
49,389 |
|
|
|
(433 |
) |
|
|
181,357 |
|
Gross Margin |
|
|
34,566 |
|
|
|
13,618 |
|
|
|
9,300 |
|
|
|
(380 |
) |
|
|
57,104 |
|
Gross Margin % |
|
|
25.4 |
% |
|
|
30.7 |
% |
|
|
15.8 |
% |
|
|
|
|
23.9 |
% |
Selling, general and administrative |
|
|
11,950 |
|
|
|
6,038 |
|
|
|
4,484 |
|
|
|
3,246 |
|
|
|
25,718 |
|
Restructuring charges |
|
|
94 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
94 |
|
Depreciation and amortization |
|
|
6,578 |
|
|
|
2,213 |
|
|
|
3,258 |
|
|
|
133 |
|
|
|
12,182 |
|
Operating income (loss) |
|
|
15,944 |
|
|
|
5,367 |
|
|
|
1,558 |
|
|
|
(3,759 |
) |
|
|
19,110 |
|
Depreciation and amortization |
|
|
6,578 |
|
|
|
2,213 |
|
|
|
3,258 |
|
|
|
133 |
|
|
|
12,182 |
|
EBITDA |
|
|
22,522 |
|
|
|
7,580 |
|
|
|
4,816 |
|
|
|
(3,626 |
) |
|
|
31,292 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
250 |
|
|
|
250 |
|
Severance charges |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,151 |
|
|
|
1,151 |
|
Restructuring charges |
|
|
94 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
94 |
|
Adjusted EBITDA |
|
$ |
22,616 |
|
|
$ |
7,580 |
|
|
$ |
4,816 |
|
|
$ |
(2,225 |
) |
|
$ |
32,787 |
|
Adjusted EBITDA Margin % |
|
|
16.6 |
% |
|
|
17.1 |
% |
|
|
8.2 |
% |
|
|
|
|
13.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
Nine
months ended July 31, 2020 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
341,432 |
|
|
$ |
104,230 |
|
|
$ |
152,634 |
|
|
$ |
(2,128 |
) |
|
$ |
596,168 |
|
Cost of sales |
|
|
266,489 |
|
|
|
72,055 |
|
|
|
132,259 |
|
|
|
(1,217 |
) |
|
|
469,586 |
|
Gross Margin |
|
|
74,943 |
|
|
|
32,175 |
|
|
|
20,375 |
|
|
|
(911 |
) |
|
|
126,582 |
|
Gross Margin % |
|
|
21.9 |
% |
|
|
30.9 |
% |
|
|
13.3 |
% |
|
|
|
|
21.2 |
% |
Selling, general and administrative |
|
|
34,962 |
|
|
|
15,990 |
|
|
|
13,468 |
|
|
|
(1,602 |
) |
|
|
62,818 |
|
Restructuring charges |
|
|
228 |
|
|
|
- |
|
|
|
249 |
|
|
|
- |
|
|
|
477 |
|
Depreciation and amortization |
|
|
18,311 |
|
|
|
7,045 |
|
|
|
10,139 |
|
|
|
356 |
|
|
|
35,851 |
|
Operating income (loss) |
|
|
21,442 |
|
|
|
9,140 |
|
|
|
(3,481 |
) |
|
|
335 |
|
|
|
27,436 |
|
Depreciation and amortization |
|
|
18,311 |
|
|
|
7,045 |
|
|
|
10,139 |
|
|
|
356 |
|
|
|
35,851 |
|
EBITDA |
|
|
39,753 |
|
|
|
16,185 |
|
|
|
6,658 |
|
|
|
691 |
|
|
|
63,287 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
55 |
|
|
|
55 |
|
Executive severance charges |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,343 |
|
|
|
1,343 |
|
Restructuring charges |
|
|
228 |
|
|
|
- |
|
|
|
249 |
|
|
|
- |
|
|
|
477 |
|
Adjusted EBITDA |
|
$ |
39,981 |
|
|
$ |
16,185 |
|
|
$ |
6,907 |
|
|
$ |
2,089 |
|
|
$ |
65,162 |
|
Adjusted EBITDA Margin % |
|
|
11.7 |
% |
|
|
15.5 |
% |
|
|
4.5 |
% |
|
|
|
|
10.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
Nine
months ended July 31, 2019 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
360,654 |
|
|
$ |
121,203 |
|
|
$ |
175,377 |
|
|
$ |
(3,762 |
) |
|
$ |
653,472 |
|
Cost of sales |
|
|
278,877 |
|
|
|
84,139 |
|
|
|
150,944 |
|
|
|
(2,668 |
) |
|
|
511,292 |
|
Gross Margin |
|
|
81,777 |
|
|
|
37,064 |
|
|
|
24,433 |
|
|
|
(1,094 |
) |
|
|
142,180 |
|
Gross Margin % |
|
|
22.7 |
% |
|
|
30.6 |
% |
|
|
13.9 |
% |
|
|
|
|
21.8 |
% |
Selling, general and administrative |
|
|
37,240 |
|
|
|
17,444 |
|
|
|
13,914 |
|
|
|
8,868 |
|
|
|
77,466 |
|
Restructuring charges |
|
|
281 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
281 |
|
Depreciation and amortization |
|
|
20,208 |
|
|
|
6,669 |
|
|
|
9,902 |
|
|
|
379 |
|
|
|
37,158 |
|
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Operating income (loss) |
|
|
24,048 |
|
|
|
12,951 |
|
|
|
(29,361 |
) |
|
|
(10,341 |
) |
|
|
(2,703 |
) |
Depreciation and amortization |
|
|
20,208 |
|
|
|
6,669 |
|
|
|
9,902 |
|
|
|
379 |
|
|
|
37,158 |
|
EBITDA |
|
|
44,256 |
|
|
|
19,620 |
|
|
|
(19,459 |
) |
|
|
(9,962 |
) |
|
|
34,455 |
|
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,217 |
|
|
|
1,217 |
|
Severance related to reorganization |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,301 |
|
|
|
2,301 |
|
Restructuring charges |
|
|
281 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
281 |
|
Adjusted EBITDA |
|
$ |
44,537 |
|
|
$ |
19,620 |
|
|
$ |
10,519 |
|
|
$ |
(6,444 |
) |
|
$ |
68,232 |
|
Adjusted EBITDA Margin % |
|
|
12.3 |
% |
|
|
16.2 |
% |
|
|
6.0 |
% |
|
|
|
|
10.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS
CORPORATIONSALES ANALYSIS(In
thousands)(Unaudited)
|
|
Three
Months Ended |
|
Nine Months
Ended |
|
|
July 31,
2020 |
|
July 31,
2019 |
|
July 31,
2020 |
|
July 31,
2019 |
|
|
|
|
|
|
|
|
|
NA Fenestration: |
|
|
|
|
|
|
|
|
United States - fenestration |
$ |
109,455 |
|
|
$ |
119,481 |
|
|
$ |
302,094 |
|
|
$ |
312,509 |
|
|
International - fenestration |
|
6,696 |
|
|
|
7,172 |
|
|
|
19,284 |
|
|
|
23,474 |
|
|
United
States - non-fenestration |
|
4,845 |
|
|
|
3,982 |
|
|
|
13,779 |
|
|
|
12,290 |
|
|
International - non-fenestration |
|
1,390 |
|
|
|
5,624 |
|
|
|
6,275 |
|
|
|
12,381 |
|
|
|
$ |
122,386 |
|
|
$ |
136,259 |
|
|
$ |
341,432 |
|
|
$ |
360,654 |
|
EU Fenestration
(1): |
|
|
|
|
|
|
|
|
International - fenestration |
$ |
31,904 |
|
|
$ |
36,342 |
|
|
$ |
87,732 |
|
|
$ |
102,038 |
|
|
International - non-fenestration |
|
6,361 |
|
|
|
7,984 |
|
|
|
16,498 |
|
|
|
19,165 |
|
|
|
$ |
38,265 |
|
|
$ |
44,326 |
|
|
$ |
104,230 |
|
|
$ |
121,203 |
|
NA Cabinet Components: |
|
|
|
|
|
|
|
|
United
States - fenestration |
$ |
2,666 |
|
|
$ |
3,561 |
|
|
$ |
8,461 |
|
|
$ |
9,909 |
|
|
United
States - non-fenestration |
|
48,849 |
|
|
|
54,512 |
|
|
|
142,838 |
|
|
|
163,694 |
|
|
International - non-fenestration |
|
410 |
|
|
|
616 |
|
|
|
1,335 |
|
|
|
1,774 |
|
|
|
$ |
51,925 |
|
|
$ |
58,689 |
|
|
$ |
152,634 |
|
|
$ |
175,377 |
|
Unallocated Corporate & Other: |
|
|
|
|
|
|
|
|
Eliminations |
$ |
(480 |
) |
|
$ |
(813 |
) |
|
$ |
(2,128 |
) |
|
$ |
(3,762 |
) |
|
|
$ |
(480 |
) |
|
$ |
(813 |
) |
|
$ |
(2,128 |
) |
|
$ |
(3,762 |
) |
|
|
|
|
|
|
|
|
|
Net Sales |
$ |
212,096 |
|
|
$ |
238,461 |
|
|
$ |
596,168 |
|
|
$ |
653,472 |
|
|
|
|
|
|
|
|
|
|
(1) Reflects reduction
of $0.4 million and $1.6 million in revenue associated with foreign
currency exchange rate impacts for the three and nine months ended
July 31, 2020, respectively. |
Quanex (NYSE:NX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quanex (NYSE:NX)
Historical Stock Chart
From Apr 2023 to Apr 2024